NEW YORK (GenomeWeb News) – SomaLogic and New England Biolabs today announced an agreement for the provision of specific aptamer-based reagents to NEB for nucleic acid amplification and PCR products.
Under the terms of the deal, SomaLogic will provide certain SomaMers — which are specific protein binding reagents based on chemically modified aptamers developed by SomaLogic — to NEB to incorporate them into its products as reversible inhibitors of thermally active DNA polymerases used in PCR, the two firms said.
Financial and other terms of the agreement were not disclosed.
In a statement, Salvatore Russello, associate director of business development at NEB, said that there are many opportunities to improve the performance of thermally active DNA polymerase in PCR reactions.
"This agreement is thus of great value to NEB and is already being used to improve the application of DNA polymerases," such as NEB's OneTaq Hot Start product, he said.